Product Information

PIOGLITAZONE HCL 15 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0647 per EA under NDC 82009010305. Its NADAC has been published 143 times since Nov 29, 2023.

FDA first approved this application on Feb 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 15 MG TABLET

pioglitazone hydrochloride
$0.0647per EA

Strength

15 mg/1

NDC

82009010305

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA200268

FDA Approved

2/13/2013

TE Code

AB

On Market Since

8/1/2023

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 15 MG TABLET has been published 143 times since Nov 29, 2023, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0647 per EA
All-time high$0.0925 (Jan 10, 2024)
All-time low$0.0587 (Nov 20, 2024)
52-week high$0.0727
52-week low$0.0647
Median price$0.0723
Average price$0.0740
Largest weekly change-25.8% (Nov 20, 2024)
Weeks tracked143
Tracking sinceNov 29, 2023

Price History

1W

-2.2%

1M

-2.2%

3M

-7.7%

6M

-5.6%

1Y

-11.0%

3Y

N/A

5Y

N/A

All

-28.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 15 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0647 per EA (NDC 82009010305), effective Aug 19, 2026.

How has the price of PIOGLITAZONE HCL 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has declined 28.0%. It has been tracked across 143 weekly CMS publications since Nov 29, 2023.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 15 MG TABLET?

Since Nov 29, 2023, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has ranged from a low of $0.0587 (Nov 20, 2024) to a high of $0.0925 (Jan 10, 2024), with a median of $0.0723 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 15 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE HCL 15 MG TABLET?

PIOGLITAZONE HCL 15 MG TABLET (NDC 82009010305) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.